MetaADEDB 2.0 @ LMMD
indapamide, perindopril drug combination
(LRRJSCKXFJTRLC-GYFKHDNESA-N)
Structure
SMILES
CC1Cc2c(N1NC(=O)c1ccc(c(c1)S(=O)(=O)N)Cl)cccc2.CCC[C@@H](C(=O)OCC)N[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C
Molecular Formula:
C35H48ClN5O8S
Molecular Weight:
734.302
Log P:
6.5898
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
4
TPSA:
196.82
CAS Number(s):
N/A
Synonym(s)
1.
indapamide, perindopril drug combination
2.
Preterax
3.
S 5590
4.
S5590
External Link(s)
MeSHC494243
PubChem Compound56841493
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Lichen PlanusFAERS: 1US FAERS
2PancreatitisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
3PancytopeniaFAERS: 1US FAERS
4Abdominal PainCanada Vigilance: 2Canada Vigilance
5Abdominal discomfortCanada Vigilance: 2Canada Vigilance
6Acute Coronary SyndromeCanada Vigilance: 1Canada Vigilance
7Acute kidney injuryCanada Vigilance: 1Canada Vigilance
8AngioedemaCanada Vigilance: 3Canada Vigilance
9AnxietyCanada Vigilance: 1Canada Vigilance
10ArthralgiaCanada Vigilance: 1Canada Vigilance
11AstheniaCanada Vigilance: 1Canada Vigilance
12Blood creatinine increasedCanada Vigilance: 1Canada Vigilance
13Blood urea increasedCanada Vigilance: 1Canada Vigilance
14BronchospasmCanada Vigilance: 1Canada Vigilance
15Chest discomfortCanada Vigilance: 3Canada Vigilance
16DehydrationCanada Vigilance: 1Canada Vigilance
17Depressed moodCanada Vigilance: 2Canada Vigilance
18DizzinessCanada Vigilance: 3Canada Vigilance
19Drug ineffectiveCanada Vigilance: 2Canada Vigilance
20Dry skinCanada Vigilance: 1Canada Vigilance
21Erectile dysfunctionCanada Vigilance: 1Canada Vigilance
22FatigueCanada Vigilance: 3Canada Vigilance
23Head discomfortCanada Vigilance: 1Canada Vigilance
24HeadacheCanada Vigilance: 4Canada Vigilance
25HypersensitivityCanada Vigilance: 1Canada Vigilance
26HypersomniaCanada Vigilance: 1Canada Vigilance
27HypotensionCanada Vigilance: 1Canada Vigilance
28Joint swellingCanada Vigilance: 1Canada Vigilance
29MalaiseCanada Vigilance: 2Canada Vigilance
30Muscle tightnessCanada Vigilance: 2Canada Vigilance
31MyalgiaCanada Vigilance: 2Canada Vigilance
32Myocardial InfarctionCanada Vigilance: 1Canada Vigilance
33NauseaCanada Vigilance: 4Canada Vigilance
34NeutropeniaCanada Vigilance: 1Canada Vigilance
35Peripheral swellingCanada Vigilance: 2Canada Vigilance
36Product quality issueCanada Vigilance: 1Canada Vigilance
37Product substitution issueCanada Vigilance: 3Canada Vigilance
38PseudomyopiaCanada Vigilance: 1Canada Vigilance
39Pulmonary FibrosisCanada Vigilance: 2Canada Vigilance
40SinusitisCanada Vigilance: 1Canada Vigilance
41SomnolenceCanada Vigilance: 1Canada Vigilance
42TachycardiaCanada Vigilance: 2Canada Vigilance
43ThirstCanada Vigilance: 1Canada Vigilance
44TinnitusCanada Vigilance: 1Canada Vigilance
45Urinary tract infectionCanada Vigilance: 1Canada Vigilance
46Vascular Diseases19864958CTD
47Weight decreasedCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.